₹ 1109
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Target Price
The average target price of AUROPHARMA.NS is 1275 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomm
